Notable companies
The most notable companies in this group are Sarepta Therapeutics (NASDAQ:SRPT), Guardant Health (NASDAQ:GH).
Industry description
The investment seeks long-term capital appreciation.
The fund is an actively managed exchange-traded fund (“ETF”) and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund’s investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.
Market Cap
The average market capitalization across the F/m Emerald Life Sciences Innovation ETF ETF is 3.5B. The market cap for tickers in the group ranges from 237.87M to 13.31B. UTHR holds the highest valuation in this group at 13.31B. The lowest valued company is WGS at 237.87M.
High and low price notable news
The average weekly price growth across all stocks in the F/m Emerald Life Sciences Innovation ETF ETF was 19%. For the same ETF, the average monthly price growth was 48%, and the average quarterly price growth was 131%. WVE experienced the highest price growth at 16%, while COLL experienced the biggest fall at -4%.
Volume
The average weekly volume growth across all stocks in the F/m Emerald Life Sciences Innovation ETF ETF was 15%. For the same stocks of the ETF, the average monthly volume growth was 12% and the average quarterly volume growth was 84%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 70
P/E Growth Rating: 78
Price Growth Rating: 59
SMR Rating: 83
Profit Risk Rating: 71
Seasonality Score: 0 (-100 ... +100)